Amplicon-based long-read sequencing for accurate CYP2D6 gene deletion and duplication detection using CYP2D7 as a reference gene
We developed an amplicon-based long-read sequencing approach that enables simultaneous detection of CYP2D6 single-nucleotide variants (SNVs) and copy-number variations (CNVs) in a single reaction. The SNVs of the two pseudogenes, CYP2D7 and CYP2D8, were also comprehensively characterized. CYP2D6 CNVs were inferred using CYP2D7 as a reference gene, integrating read-depth measurements with allele-frequency (AF) ratios. The entire CYP2D locus ( ~ 30.2Kb) and the three homologous genes separately (6.3-6.6Kb) were sequenced using Oxford Nanopore sequencing. Our analysis identified 21 CYP2D7 and 17 CYP2D8 unique haplotypes, and 57% of the SNVs detected in the pseudogenes had nucleotides corresponding to CYP2D6 reference nucleotides. A total of 36 variants found within the pseudogenes have also been annotated as functional variants in the CYP2D6 gene. The combined CYP2D6:CYP2D7 read-count ratio and reference-to-alternative alleles AF ratio accurately predicted CYP2D6 CNV status. This method is simple and rapid, making it potentially suitable for clinical implementation of pharmacogenomics.
Authors
- Martin Lewis (ORCID: https://orcid.org/0000-0002-3332-3776)
- David L. Adelson (ORCID: https://orcid.org/0000-0003-2404-5636)
- Michael Musker (ORCID: https://orcid.org/0000-0001-8226-8630)
- Kiflu Gebremicael Tesfamicael
Institutions
- South Australian Museum (AU)
- South Australian Research and Development Institute (AU)
- South Australian Health and Medical Research Institute (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- The Pharmacogenomics Journal
- Published
- 2026-08-26
- DOI
- https://doi.org/10.1038/s41397-026-00429-x
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00